Insights

The Liability Gap: Why Underwriting Is the Real Unlock for Clinical AI

The Experimental State Markets for Experimental Medicine

Diagnostics Isn’t Broken. Our Model for Evaluating It Is

Two Years, Two Kids, and Baby Steps for Personal Health AI

When Biotech Crowds Into Consensus, the Real Returns Begin Elsewhere

Light as Medicine: Why Photobiomodulation and Circadian Therapeutics Are Emerging as a Core Health Modality

Real ROI or Bust: Consumer Health Data Isn’t Enough

Regulation, AI, and Geopolitics: Insights from Our Latest Fireside Chat

Building Healthspan as the Next Infrastructure for Longevity

The 2AM Question: ChatGPT or MyChart?

The FDA’s Shifting Regulatory Landscape

The Future of Non-Invasive Diagnostics: Six Technologies Supercharging Preventive Health